Washington Hospital Center

Washington D.C., District of Columbia 20011

9 studies enrolling now · 265 studies all time

What they study most

ACE Inhibitor Induced Angioedema, AIDS, Abdominal Aortic Aneurysms, Acute Coronary Syndrome, Acute Coronary Syndromes, Acute Decompensated Heart Failure (ADHF), Acute Kidney Injury, Acute Lung Injury, Acute Myeloid Leukemia, Acute Myocardial Infarction, Acute Myocardial Infarction (AMI), Acute ST Elevation Myocardial Infarction

Studies at this site

• Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV — Recruiting now
• Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain — Recruiting now
• Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure — Recruiting now
• Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature — Recruiting now
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure — Recruiting now
• The DC Cohort Longitudinal HIV Status Neutral Study — Recruiting now
• Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention — Recruiting now
• Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study — Recruiting now
• VOLT-AF IDE Clinical Study — Completed
• Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer — Completed
• CHAMPION-AF Clinical Trial — Running, not enrolling
• Evaluation and Diagnosis of Potential Research Subjects With Traumatic Brain Injury — Completed
• ADVENT Post Approval Study — Running, not enrolling
• Portico Next Generation Approval Study — Running, not enrolling
• Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study — Starting soon
• Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma — Stopped early
• Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). — Running, not enrolling
• Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer — Completed
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Aveir DR i2i Study — Completed
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab — Running, not enrolling
• ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation — Enrolling by invitation
• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
• Esprit BTK Post-Approval Study — Running, not enrolling
• ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study — Completed
• Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections — Completed
• ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis — Running, not enrolling
• Outcomes of Surgically Ineligible Patients With Multivessel CAD — Completed
• Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome — Completed
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation — Completed
• S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery — Completed
• Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management — Running, not enrolling
• Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial — Running, not enrolling
• Reshaping Postpartum Follow-up — Completed
• The ARIES HeartMate 3 Pump IDE Study — Completed
• BIOTRONIK Conduction System Pacing With the Solia Lead — Completed
• AMPLATZER™ Amulet™ LAA Occluder Trial — Completed
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate — Completed
• RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty — Completed
• Art Therapy in Obstetric Patients — Completed
• Spiration Valves Against Standard Therapy — Stopped early
• S-ICD® System Post Approval Study — Completed
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk — Completed
• AdaptResponse Clinical Trial — Completed
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort — Completed
• TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation — Completed
• Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial — Status unconfirmed
• A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer — Completed
• Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment — Stopped early
• MANTA Ultrasound Closure Study — Stopped early